¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"REC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • JrId: 22500
    JournalTitle: La Recherche.
    MedAbbr: Recherche
    ISSN: 0029-5671
    ESSN:
    IsoAbbr:
    NlmId: 254763
  • JrId: 24627
    JournalTitle: Records of Buckinghamshire, or, Papers and notes on the history, antiquities, and architecture of the county, together with the proceedings of the Architectural and Archaeological Society for the County of Buckingham.
    MedAbbr: Rec Bucks
    ISSN:
    ESSN:
    IsoAbbr:
    NlmId: 100969433
  • JrId: 24629
    JournalTitle: Records of the Columbia Historical Society, Washington, D.C.
    MedAbbr: Rec Columb Hist Soc
    ISSN: 0897-9049
    ESSN:
    IsoAbbr:
    NlmId: 100969436
  • JrId: 24631
    JournalTitle: Recherches amerindiennes au Quebec.
    MedAbbr: Rech Amerindien Que
    ISSN: 0318-4137
    ESSN:
    IsoAbbr:
    NlmId: 100969439
  • JrId: 24632
    JournalTitle: Recherche sociale.
    MedAbbr: Rech Soc
    ISSN: 0034-124X
    ESSN:
    IsoAbbr:
    NlmId: 100969440
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • F33.4
    Recurrent depressive disorder, currently in remission
    Àç¹ß¼º ¿ì¿ï¼º Àå¾Ö, ÇöÀç °üÇØ »óÅÂ
  • F33.9
    Recurrent depressive disorder, unspecified
    »ó¼¼ºÒ¸íÀÇ Àç¹ß¼º ¿ì¿ï¼º Àå¾Ö
  • M24.4
    Recurrent dislocation and subluxation of joint
    °üÀýÀÇ Àç¹ß¼º Å»±¸ ¹× ºÒ¿ÏÀü Å»±¸
  • M22.0
    Recurrent dislocation of patella
    ¹«¸­»ÀÀÇ Àç¹ß¼º Å»±¸
  • K12.0
    Recurrent oral aphthae
    Àç¹ß¼º ±¸°­ ¾ÆÇÁŸ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • recoil
    µÇƦ, ¹Ý¹ß, ¹Ýµ¿
  • recoil atom
    ¹Ýµ¿¿øÀÚ, µÇƦ¿øÀÚ
  • recoil proton
    ¹Ýµ¿¾ç¼ºÀÚ
  • recoil wave
    ºÒ±ÔÄ¢ÆÄ
  • recollection
    Àç¼öÁý
  • recoloring
    º¹»ö
  • recombinant
    1. ÀçÁ¶ÇÕü-, ÀçÁ¶ÇÕ- 2. ÀçÁ¶ÇÕÇü- 3. ÀçÁ¶ÇÕü 4. ÀçÁ¶ÇÕÇü
  • recombinant antigen
    ÀçÁ¶ÇÕÇ׿ø
  • recombinant chromosome
    ÀçÁ¶ÇÕ¿°»öü
  • recombinant DNA technology
    ÀçÁ¶ÇÕDNA±â¼ú
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å
  • recombination
    1. ÀçÁ¶ÇÕ 2. Àç°áÇÕ
  • recombination frequency
    ÀçÁ¶ÇÕºóµµ
  • recombination rate
    1. ÀçÁ¶ÇÕ·ü 2. Àç°áÇÕ·ü
  • recombinational repair
    ÀçÁ¶ÇÕº¹±¸
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 7 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • recumbent position
    ´©¿îÀÚ¼¼
  • recurettage
    µÇ±Ü¾î³¿¼ú
  • recurrence
    Àç¹ß
  • recurrent
    1.µÇµ¹ÀÌ-, 2. Àç¹ß-, ¹Ýº¹-
  • recurrent dislocation
    Àç¹ßÅ»±¸
  • recurrent laryngeal nerve
    µÇµ¹ÀÌÈĵνŰæ
  • recurrent subluxation
    Àç¹ßºÎºÐÅ»±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • reciprocal inhibition
    »ó¹Ý¾ïÁ¦, »óÈ£¾ïÁ¦
  • reciprocal inhibition psychotherapy
    »óÈ£¾ïÁ¦Á¤½Å¿ä¹ý
  • reciprocal innervation
    »ó¹Ý½Å°æºÐÆ÷, »óÈ£½Å°æºÐÆ÷
  • reciprocal parasitism
    »óÈ£±â»ý
  • reciprocal rhythm
    Àç±Í¸®µë
  • reciprocal shaker
    ¿Õº¹ÁøÅÁ±â
  • reciprocating gait orthosis
    »ó¹Ýº¸ÇຸÁ¶±â
  • recirculation
    Àç¼øÈ¯
  • recirculation time
    Àç¼øÈ¯½Ã°£
  • reclaimed
    ±³Á¤-
  • reclaimed gypsum
    ±³Á¤¼®°í
  • reclaiming process
    Àç»ý¹ý
  • reclamation
    ÀçÀÌ¿ë
  • recognition
    ÀÎÁö, ÀνÄ, ÀçÀνÄ
  • recoil
    ¹Ýµ¿, µÇƦ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • recessus inferior omentalis ³ª
    ¸Á³¶¾Æ·¡¿À¸ñ, ÇÏÇÔ¿ä(ù»ùèèê).
  • recessus infundibuli ³ª
    ±ò¶§±â¿À¸ñ, ´©µÎÇÔ¿ä(רÔéùèèê).
  • recessus interdentalis ³ª
    Ä¡¾Æ»çÀÌ¿À¸ñ<ÀÌ»çÀÌ¿À¸ñ>, Ä¡±Ù¿Í(öÍÐÆèÀ).
  • recessus intersigmoideus ³ª
    SÀÚ°áÀå»çÀÌ¿À¸ñ, S»ó°áÀå°£ÇÔ¿ä(¡­ßÒÌ¿ Êàùèèê ).
  • recessus isthmicus ³ª
    Á¼Àº¿À¸ñ, ÇùÇÔ¿ä( ùèèê).
  • recessus lateralis ventriculi quarti ³ª
    ³Ý°³ú½Ç¿ÜÃø¿À¸ñ, Á¦4³ú½Ç¿ÜÃøÇÔ ¿ä(ð¯ÞÌÒàãøèâö° ùèèê).
  • recessus lienalis ³ª
    ºñÀå¿À¸ñ, ºñÇÔ¿ä (Þ¡ùèèê).
  • recessus membranae tympani aboralis ³ª
    °í¸·(ÍÕØ¯).
  • recessus membranae tympani anterior ³ª
    ¾Õ°í¸·¿À¸ñ, Àü°í¸·ÇÔ¿ä(îñÍÕØ¯ùèèê ).
  • recessus membranae tympani posterior ³ª
    µÚ°í¸·¿À¸ñ, ÈÄ°í¸·ÇÔ¿ä(ý­ÍÕØ¯ùè èê).
  • recessus membranae tympani superior ³ª
    À§°í¸·¿À¸ñ, »ó°í¸·ÇÔ¿ä(ß¾ÍÕØ¯ùèèê ).
  • recessus nasopalatinus ³ª
    ÄÚ±¸°³¿Í, ºñ±¸°³ÇÔ¿ä(ެϢËÏùèèê).
  • recessus opticus ³ª
    ½Ã°¢±³Â÷¿À¸ñ, ½Ã±³Â÷ÇÔ¿ä(ãÊÎßó¬ùèèê).
  • recessus orbito ethmoidalis ³ª
    ¾È¿Í»ç°ñ¿À¸ñ, ¾È¿Í»ç°ñ¿Í(äÑèÀÞèÍéèÀ).
  • recessus palatinum ³ª
    ±¸°³¿À¸ñ, ±¸°³ÇÔ¿ä(Ï¢ËÏùèèê).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • recession of muscle
    ±ÙÈÄÀü(¼ú)
  • recession of muscle
    ±Ù ÅðÃà.
  • recession of muscle
    ±ÙÅðÃà(ÐÉ÷Üõî)
  • recession operation
    ÈÄÀü¼ú
  • recessivation
    ¿­¼ºÈ­(æëàõûù).
  • recessive
    ¿­¼º(æëàõ)
  • recessive
    ¿­¼º(æëàõ)ÀÇ
  • recessive
    ¿­¼ºÀÇ.
  • recessive
    ¿­¼ºÇüÁú.
  • recessive autosomal gene
    ¿­¼ºº¸Åë¿°»öüÀ¯ÀüÀÚ
  • recessive character
    ¿­¼ºÇüÁú(¡­û¡òõ).
  • recessive dystrophic epidermolysis bullosa
    ¿­¼º ¿µ¾çÀå¾Ö ¼öÆ÷ Ç¥Çǹڸ®Áõ
  • recessive gene
    ¿­¼ºÀ¯ÀüÀÚ
  • recessive gene
    ¿­¼ºÀ¯ÀüÀÚ(¡­ë¶îîí­).
  • recessive gonosomal gene
    ¿­¼º¼º¿°»öüÀ¯ÀüÀÚ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • reconstruction algorithm
    À籸¼º ¿¬»ê
  • reconstructive transition
    Àç°Ç ÀüÀÌ
    ÃÖ±ÙÁ¢ ¹èÀ§´Â º¯ÇÏÁö ¾ÊÁö¸¸, ´ÙÀ½ÀÇ ÀÎÁ¢¿øÀÚ¸¦ ÇöÀúÇÏ°Ô À̵¿½ÃŰ°Å³ª °áÇÕÀ» Àü´ÜÇÔ¿¡ ÀÇÇØ »õ·Î¿î ±¸Á¶¸¦ ¸¸µå´Â ÀüÀÌ.
  • reconvalescence :

    record

    ±â·Ï
    ÇöÀç ¶Ç´Â ÀÌÀü¿¡ Á¸ÀçÇÑ Æ¯º°ÇÑ Á¶°Ç°ú °ü·ÃµÈ ±â·Ï ÀÚ·á.
  • record cast
    ±â·Ï ¸ðÇü
    Ä¡¿­°ú °ü·Ã ±¸Á¶¹°ÀÇ ¾çÇü º¹Á¦¹°·Î¼­, ÁÖ¾îÁø ´ç½ÃÀÇ »óŸ¦ Âü°íÇϱâ À§ÇØ »ç¿ëµÈ´Ù.
  • recorder
    ±â·Ï±â
  • recovery movement
    º¹±Í ¿îµ¿
  • recovery room
    ȸº¹½Ç
    ¼ö¼ú ÈÄ ¶Ç´Â »êÈÄÀÇ È¯ÀÚ°¡, °¢°¢ º´½ÇÀ̳ª º´µ¿ÀÇ °£È£ üÁ¦ÇÏ¿¡¼­ ¾ÈÀüÀ» ã±â±îÁöÀÇ °£È£¸¦ ¸ñÀûÀ¸·Î ¼ö¼ú½ÇÀ̳ª »ê½Ç¿¡ ÀÎÁ¢ÇÏ¿© Ư¼öÇÑ ÀåÄ¡¿Í ÀοøÀ» °®Ãá º´¿øÀÇ ¹æ.
  • recrudescence
    Àç¹ß
    ÀϽÃÀûÀ¸·Î º´ÀÌ È£ÀüµÈ ÈÄ, Áõ»óÀÌ ´Ù½Ã ³ªÅ¸³ª´Â °Í.
  • recruitment of muscle
    ±ÙÀ°ÀÇ µ¿¿ø, ±ÙÀ°ÀÇ Á¡Áõ
    Áö¼ÓÀûÀÎ Àڱؿ¡ ´ëÇØ ÃÖ´ë°¡ µÉ ¶§±îÁö Ȱ¼º ±ÙÀ° ´ÜÀ§ÀÇ ¼ö°¡ Á¡Â÷ Áõ°¡ÇÏ´Â °Í.
  • recrystallization temperature
    Àç°áÁ¤ ¿Âµµ
    Àç°áÁ¤ÀÌ ÀϾ´Â ¿Âµµ.
  • rectal administration
    Á÷Àå Åõ¿©
    ¾à¹°À» Á÷Àå¿¡ ³Ö¾î Èí¼öµÇ°Ô ÇÏ´Â Ä¡·á ¹æ¹ý.
  • rectal anesthesia
    Á÷Àå ¸¶Ãë, Á÷Àå ¸¶Ãë¹ý
    ±¹¼Ò ¸¶ÃëÁ¦¸¦ Á÷Àå ³»¿¡ ÁÖÀÔÇÏ¿© ÀÏÀ¸Å°´Â ¸¶Ãë.
  • rectal application
    Á÷Àå³» Àû¿ë
    ¾î¶² ¹°ÁúÀ» Á÷Àå¿¡ ³Ö¾î Èí¼ö½ÃÅ´À¸·Î¼­ È¿°ú¸¦ ¹ßÈÖÇÏ°Ô ÇÏ´Â °Í.
  • rectal fistula
    Á÷Àå ·ç
  • rectal reflex
    Á÷Àå ¹Ý»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
receptors, antigen, B-cell Immunoglobulin molecules on the surface of B-lymphocytes that recognise and bind antigen.
(12 Dec 1998)
receptors, antigen, T-cell Molecules on the surface of T-lymphocytes that recognise and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (antigens, CD3). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (receptors, antigen, T-cell, alpha-beta) or gamma-delta (receptors, antigen, T-cell, gamma-delta) chains.
(12 Dec 1998)
receptors, antigen, T-cell, alpha-beta T-cell receptors composed of CD3-associated alpha and beta polypeptide chains and expressed primarily in CD4+ or CD8+ T-cells. Unlike immunoglobulins, the alpha-beta T-cell receptors recognise antigens only when presented in association with major histocompatibility (MHC) molecules.
(12 Dec 1998)
receptors, antigen, T-cell, gamma-delta T-cell receptors composed of CD3-associated gamma and delta polypeptide chains and expressed primarily in CD4-/CD8- T-cells. The receptors appear to be preferentially located in epithelial sites and probably play a role in the recognition of bacterial antigens. The T-cell receptor gamma/delta chains are separate and not related to the gamma and delta chains which are subunits of CD3 (see antigens, CD3).
(12 Dec 1998)
receptors, aryl hydrocarbon Cytoplasmic proteins that bind certain aryl hydrocarbons, translocate to the nucleus, and activate transcription of particular DNA segments. Ah receptors are identified by their high-affinity binding to several carcinogenic or teratogenic environmental chemicals including polycyclic aromatic hydrocarbons found in cigarette smoke and smog, heterocyclic amines found in cooked foods, and halogenated hydrocarbons including dioxins and polychlorinated biphenyls. No endogenous ligand has been identified, but an unknown natural messenger with a role in cell differentiation and development is suspected.
(12 Dec 1998)
receptors, atrial natriuretic factor Cell surface proteins that bind atrial natriuretic factor with high affinity and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
receptors, biogenic amine Cell surface proteins that bind biogenic amines with high affinity and regulate intracellular signals which influence the behaviour of cells. Biogenic amine is a chemically imprecise term which, by convention, includes the catecholamines epinephrine, norepinephrine, and dopamine, the indoleamine serotonin, the imidazolamine histamine, and compounds closely related to each of these.
(12 Dec 1998)
receptors, bombesin Cell surface proteins that bind bombesin or closely related peptides with high affinity and trigger intracellular changes influencing the behaviour of cells. Gastrin- releasing peptide (grp), grp 18-27 (neuromedin c), and neuromedin b are endogenous ligands of bombesin receptors in mammals.
(12 Dec 1998)
receptors, bradykinin Cell surface receptors that bind bradykinin and related kinins with high affinity and trigger intracellular changes which influence the behaviour of cells. The identified receptor types (b-1 and b-2, or bk-1 and bk-2) recognise the endogenous kallidins, t-kinins, and certain bradykinin fragments as well as bradykinin itself.
(12 Dec 1998)
receptors, calcitonin Cell surface proteins that bind calcitonin and trigger intracellular changes which influence the behaviour of cells. Calcitonin receptors outside the nervous system mediate the role of calcitonin in calcium homeostasis. The role of calcitonin receptors in the brain is not well understood.
(12 Dec 1998)
receptors, calcitonin gene-related peptide Cell surface proteins that bind calcitonin gene-related peptide (cgrp) with high affinity and trigger intracellular changes which influence the behaviour of cells. Cgrp receptors are present in both the central nervous system and the periphery and are not the same as calcitonin receptors.
(12 Dec 1998)
receptors, calcitriol Proteins, usually found in the cytoplasm, that specifically bind calcitriol, migrate to the nucleus, and regulate transcription of specific segments of DNA. Vitamin d is converted in the liver and kidney to calcitriol and ultimately acts through these receptors.
(12 Dec 1998)
receptors, catecholamine Cell surface proteins that bind catecholamines with high affinity and trigger intracellular changes which influence the behaviour of cells. The catecholamine messengers epinephrine, norepinephrine, and dopamine are synthesised from tyrosine by a common biosynthetic pathway.
(12 Dec 1998)
receptors, ccr5 Seven-transmembrane G-protein-coupled receptors for beta-chemokines. They also function as fusion cofactors for macrophage-tropic HIV-1 strains.
(12 Dec 1998)
receptors, cell surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behaviour of the target cell. Cell surface receptors, unlike enzymes, do not chemically alter their ligands.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 5
  • Receptor, Endothelin B - »õâ A subtype of endothelin receptor found predominantly in the KIDNEY. It may play a role in reducing systemic ENDOTHELIN levels.
    Synonyms : Endothelin B-2 Receptors, Endothelin B 2 Receptor, Endothelin B 2 Receptors, Endothelin B Receptor, Receptor, Endothelin B-2, Receptors, Endothelin B, Receptors, Endothelin B-2
  • Receptor, EphA1 - »õâ The founding member of the Eph family receptors. It was first cloned from an erythropoietin-producing human hepatocellular carcinoma cell line and is highly conserved among many mammalian species. Overproduction of the EphA1 receptor is associated with tumors and tumor cells of epithelial origin. It is also expressed at high levels in LIVER; LUNG; and KIDNEY; which is in contrast to many other members of the Eph receptor that are found primarily in tissues of the nervous system.
    Synonyms : EPHA1 Protein, EPHA1 Receptor Tyrosine Kinase, Eph Receptor
  • Receptor, EphA2 - »õâ An Eph family receptor found abundantly in tissues of epithelial origin. It is expressed in a diverse array of tissues during embryonic development, suggesting that it may play a role in embryogenesis. In adult tissues high levels of the receptor are expressed in the LUNG; SKIN; SMALL INTESTINE and OVARY.
    Synonyms : EphA2 Protein, EphA2 Receptor, EphA2 Receptor Tyrosine Kinase, EphA2-Tyrosine Kinase, Epithelial Cell Kinase Protein, Mammary-Derived Tyrosine Kinase 2, EphA2 Tyrosine Kinase, Mammary Derived Tyrosine Kinase 2
  • Receptor, EphA3 - »õâ An eph family receptor that is found primarily in adult BRAIN and variety of tissues in the developing embryo tissues. During embryonic development high levels of EphA3 receptor expression is seen in the nervous system and coincides with neuronal cell migration, suggesting a role for this protein in axonal pathfinding.
    Synonyms : Cek4 Eph Receptor, Cek4 Receptor Protein-Tyrosine Kinase, Eph Receptor Cek4, EphA3 Protein, Cek4 Receptor Protein Tyrosine Kinase, Cek4, Eph Receptor, Eph Receptor, Cek4
  • Receptor, EphA4 - »õâ An eph family receptor found in variety of tissues including BRAIN. During embryogenesis, EphA4 receptor exhibits a diverse spatial and temporal pattern of expression suggesting its role in multiple developmental processes.
    Synonyms : Cek-8 Kinase, Eph-A4 Receptor Tyrosine Kinase, EphA4 Protein, Ephrin Receptor A4, Receptor Tyrosine Kinase Eph-A4, Sek-1 Receptor Tyrosine Kinase, Cek 8 Kinase, Eph A4 Receptor Tyrosine Kinase, Receptor Tyrosine Kinase Eph A4, Sek 1 Receptor Tyrosine Kinase
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 5 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
º£³×ÇȽºÁÖ(Ç÷¾×ÀÀ°íÀÎÀÚIX(À¯ÀüÀÚÀçÁ¶ÇÕ))250IU/V - »õâ
Çѱ¹¿ÍÀ̾
Recombinant blood coagulation factor IX
Àü¹®ÀǾàǰ | ºñ±Þ¿©
º£³×ÇȽºÁÖ(Ç÷¾×ÀÀ°íÀÎÀÚIX(À¯ÀüÀÚÀçÁ¶ÇÕ))500IU/V - »õâ
Çѱ¹¿ÍÀ̾
Recombinant blood coagulation factor IX
Àü¹®ÀǾàǰ | ºñ±Þ¿©
º£³×ÇȽºÁÖ(Ç÷¾×ÀÀ°íÀÎÀÚIX(À¯ÀüÀÚÀçÁ¶ÇÕ))260IU - »õâ
Wyeth
Recombinant blood coagulation factor IX
Àü¹®ÀǾàǰ | ºñ±Þ¿©
º£³×ÇȽºÁÖ(Ç÷¾×ÀÀ°íÀÎÀÚIX(À¯ÀüÀÚÀçÁ¶ÇÕ))510IU - »õâ
Wyeth
Recombinant blood coagulation factor IX
Àü¹®ÀǾàǰ | ºñ±Þ¿©
º£³×ÇȽºÁÖ(Ç÷¾×ÀÀ°íÀÎÀÚIX(À¯ÀüÀÚÀçÁ¶ÇÕ))520IU - »õâ
Wyeth
Recombinant blood coagulation factor IX
Àü¹®ÀǾàǰ | ºñ±Þ¿©
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
receiver set that receives radio or tv signals liquidator: (law) a person (usually appointed by a court of law) who liquidates assets or preserves them for the benefit of affected parties telephone receiver: earphone that converts electrical signals into sounds recipient: a person who gets something a football player who catches (or is supposed to catch) a forward pass
Ãâó: wordnet.princeton.edu/perl/webwn
rectum the terminal section of the alimentary canal; from the sigmoid flexure to the anus
Ãâó: wordnet.princeton.edu/perl/webwn
recurrence happening again (especially at regular intervals); "the return of spring"
Ãâó: wordnet.princeton.edu/perl/webwn
receptor a cellular structure that is postulated to exist in order to mediate between a chemical agent that acts on nervous tissue and the physiological response sense organ: an organ having nerve endings (in the skin or viscera or eye or ear or nose or mouth) that respond to stimulation
Ãâó: wordnet.princeton.edu/perl/webwn
recession the state of the economy declines; a widespread decline in the GDP and employment and trade lasting from six months to a year recess: a small concavity the withdrawal of the clergy and choir from the chancel to the vestry at the end of a church service the act of ceding back receding: the act of becoming more distant
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Received Pronunciation
    ¿ëÀÎ ¹ßÀ½(Received Standard (English)ÀÇ ¹ßÀ½)
  • received Standard (English)
    ¿ëÀΠǥÁØ ¿µ¾î(¿µ±¹ÀÇ public school ¹× Oxfo rd,Cambridge´ëÇÐ Ãâ½ÅÀÚ°¡ ¾²´Â ¿µ¾î)
  • receiver
    ¼öÃëÀÎ
  • receiver
    ¹Þ´Â »ç¶÷;¼öÃëÀÎ;¼ö³³¿ø;Á¢´ëÇÏ´Â »ç¶÷;(ÆÄ»êµÈ)Àç»ê °ü¸®ÀÎ;°èÀï Àç»ê ¼öŹ °ü¸®ÀÚ;¼öÀÍ °ü¸®ÀÎ;¸®½Ã¹ö;ÀÀÀüÇÏ´Â »ç¶÷;°í¸ÅÀÚ(Àå¹°ÀÇ);±×¸©;¹Þ´Â(¸ðÀ¸´Â)±×¸©;°¡½º ÅÊÅ©;¹è±â½Ç(¹è±âÁ¾ÀÇ);¼öÈ­±â;¼ö½Å±â;¸®½Ã¹ö;¼ö»ó±â(ÅÚ·¹ºñÀüÀÇ);~ship °üÀçÀÎÀÇ Á÷(ÀÓ±â);Àç»ê °ü¸®(¸¦
  • receiver general
    (MassachusettsÁÖÀÇ)¼¼ÀÔ Â¡¼ö Àå°ü
  • receiving
    ¹Þ´Â;ȯ¿µÀÇ;¼ö½ÅÀÇ;¹ÞÀ½;°í¸Å(Àå¹°ÀÇ)
  • receiving blanket
    ¸ñ¿åÈÄ¿¡ ¸öÀ» ½Î´Â ´ã¿ä(À¯¾Æ¿ë)
  • receiving end
    ¹Þ´Â ÂÊ;½È¾îµµ ¹Þ¾ÆµéÀÏ ¼ö ¹Û¿¡ ¾ø´Â »ç¶÷;Èñ»ýÀÚ;Æ÷¼öÀÇ ¼öºñ À§Ä¡
  • receiving line
    (¸®¼Á¼Ç µîÀÇ)¿µÁ¢ ¿­
  • receiving order
    (ÆÄ»ê Àç»êÀÇ)°ü¸® ¸í·É(¼­)
  • receiving set
    ¼ö½Å(¼ö»ó)±â
  • receiving ship
    ½Åº´ ¿¬½ÀÇÔ
  • recency
    ÃÖ½Å;»õ·Î¿ò(recentness)
  • recension
    ±³Á¤;±³Á¤º»(ÆÇ)
  • recent
    ÃÖ±ÙÀÇ,»õ·Î¿î
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 5
REC the act of becoming more distant
REC a slow or gradual disappearance
REC moving toward a position farther from the front
REC (of a hairline e.g.) moving slowly back
REC the act of receiving
REC an acknowledgment (usually tangible) that payment has been made
REC mark or stamp as paid
REC report the receipt of
REC the entire amount of income before any deductions are made
REC awaiting payment
REC money that you currently expect to receive from notes or accounts
REC convert into sounds or pictures, of incoming radio signals
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 5
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á